These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 56589)

  • 1. Inhibition of frusemide-induced hyperreninaemia by growth-hormone release-inhibiting hormone in man.
    Rosenthal J; Raptis S; Escobar-Jimenez F; Pfeiffer EF
    Lancet; 1976 Apr; 1(7963):772-4. PubMed ID: 56589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of growth hormone-release inhibiting hormone (somatostatin) on the renin aldosterone system.
    Gomez-Pan A; Snow MH; Piercy DA; Robson V; Wilkinson R; Hall R; Evered DC
    J Clin Endocrinol Metab; 1976 Jul; 43(1):240-3. PubMed ID: 947943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of synthetic somatostatin on endotoxin-induced changes of growth hormone, cortisol and insulin in plasma, blood sugar and blood leukocytes in man.
    Wagner H; Zierden E; Hauss WH
    Klin Wochenschr; 1975 Jun; 53(11):539-41. PubMed ID: 1152345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of ibuprofen and indomethacin upon renal haemodynamics and electrolyte excretion in the presence and absence of frusemide.
    Passmore AP; Copeland S; Johnston GD
    Br J Clin Pharmacol; 1989 Apr; 27(4):483-90. PubMed ID: 2655691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention by somatostatin of rise in blood pressure and plasma renin mediated by beta-receptor stimulation.
    Rosenthal J; Escobar-Jimenez F; Raptis S
    Clin Endocrinol (Oxf); 1977 Jun; 6(6):455-62. PubMed ID: 884878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the plasma-aldosterone response to frusemide by bromocriptine.
    Edwards CR; Miall PA; Hanker JP; Thorner MO; Al-Dujaili EA; Besser GM
    Lancet; 1975 Nov; 2(7941):903-5. PubMed ID: 53377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of somatostatin on abnormal GH response to TRH in primary hypothyroidism.
    Baldini M; Catania A; Orsatti A; Manfredi MG; Motta P; Cantalamessa L
    Exp Clin Endocrinol; 1992; 99(2):80-3. PubMed ID: 1353454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone secretion and pancreatic function following somatostatin infusion in ducks (Anas platyrhynchos).
    Strosser MT; Harvey S; Foltzer C; Mialhe P
    Br Poult Sci; 1985 Jul; 26(3):425-32. PubMed ID: 2862973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Analogues of growth-hormone release-inhibiting hormone.
    Evered DC; Gomez-Pan A; Tunbridge WM; Hall R; Lind T; Besser GM; Mortimer CH; Thorner MO; Schally AV; Kastin AJ; Coy DH
    Lancet; 1975 May; 1(7918):1250. PubMed ID: 48882
    [No Abstract]   [Full Text] [Related]  

  • 10. The suppression of blood growth hormone level by somatostatin infusion in patients with active acromegaly.
    Kwok CF; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Oct; 42(4):249-54. PubMed ID: 2907415
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of oxindanac and frusemide in man.
    Tamm C; Favre L; Spence S; Pfister S; Vallotton MB
    Eur J Clin Pharmacol; 1989; 37(1):17-21. PubMed ID: 2687006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of ibuprofen and indomethacin on renal function in the presence and absence of frusemide in healthy volunteers on a restricted sodium diet.
    Passmore AP; Copeland S; Johnston GD
    Br J Clin Pharmacol; 1990 Mar; 29(3):311-9. PubMed ID: 2178660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
    Ward FR; Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of ketoprofen and frusemide in man.
    Wa TC; Lawson M; Jackson SH; Hitoglou-Makedou A; Turner P
    Postgrad Med J; 1991 Jul; 67(789):655-8. PubMed ID: 1924052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of urinary antidiuretic hormone in man: stimulation-suppression tests.
    Fressinaud P; Corvol P; Menard J
    Kidney Int; 1974 Sep; 6(3):184-90. PubMed ID: 4422829
    [No Abstract]   [Full Text] [Related]  

  • 16. An in vivo model for testing somatostatin suppression of growth hormone release in sheep.
    Redekopp C; Barrier LD; Livesey JH; Donald RA
    J Endocrinol Invest; 1980; 3(3):237-41. PubMed ID: 6153047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of somatostatin on basal levels of plasma growth hormone and insulin in acromegalics: dose-response studies and attempted total growth hormone suppression.
    Christensen SE; Nerup J; Hansen AP; Lundbaek K
    J Clin Endocrinol Metab; 1976 May; 42(5):839-45. PubMed ID: 773950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that endogenous somatostatin (SRIF) exerts a tonic inhibitory effect on the rat renin--angiotensin--aldosterone system.
    Mazzocchi G; Malendowicz LK; Meneghelli V; Nussdorfer GG
    In Vivo; 1992; 6(1):9-12. PubMed ID: 1352707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cylic and linear forms of somatostatin in the inhibiton of growth hormone, insulin and glucagon Secretion.
    Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 May; 40(5):906-8. PubMed ID: 1127098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.